Skip to content

Effect of pomegrade vinegar consumption on body fat reduction in obesity adults

Effect of pomegrade vinegar consumption for 8 weeks on body fat reduction in obesity adults : a randomized, double-blind, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000276
Enrollment
78
Registered
2011-11-24
Start date
2011-12-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Consumption of 100ml pomegrade vinegar beverages, 2 times/day

Sponsors

Ewha Womans University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Voluntarily agree to participate and sign in informed consent form 2) Women aged 20-65 years 3) BMI: 25kg/m2 = ~ = 35kg/m2

Exclusion criteria

Exclusion criteria: 1) Continuous consumption of antiobesity drugs(absorption inhibitors, antidepressants, anorexing agents), diuretic, contraceptive, steroids, female hormone that affect body weight 2) Continuous consumption of dietary supplement or oriental medicine within 4 weeks before the first visit 3) Consumption of dietary supplement for body weight control or participation in commercial obesity program within 12 weeks before first visit 4) Following diseases: ? Uncontrolled hypertension (=140/90mmHg) ? Diabetes (fasting blood glucose =126 mg/dL) ? Liver dysfunction (AST, ALT = 2.5 times of the upper limit of normal level) ? Renal dysfunction(Creatinine=1.2mg/dL) ? Hyperthiroidism and hypothyroidism ? Malignant tumors 5) Hypersensitivity to vinegar 6) Participation of another clinical trials within 4 weeks before the first visit 7) Pregnant or lactating women 8) Any condition that the principal investigator belives may put the subjects at undue risk

Design outcomes

Primary

MeasureTime frame
Total abdominal area

Secondary

MeasureTime frame
abdominal visceral and subcutaneous fat area, bady fat and lean body mass, percent body fat, plasma CRP, MCP-1, Adiponectin, leptin, gene expression in adipose tissue;plasma total cholesterol, triglycerol, HDL-cholesterol, LDL-cholesterol, Insulin, HOMA-IR, fasting blood glucose, blood pressure

Countries

Korea, Republic of

Contacts

Public ContactJiyeon Kim

Ewha Womans University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026